Literature DB >> 12270773

An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma.

Tatsuya Kishimoto1, Yasuji Soda, Yoshiko Matsuyama, Koji Mizuno.   

Abstract

OBJECTIVES: Several methods for measuring lysophosphatidylcholine (LPC) concentrations have been reported. However, these methods are not practical because they are either too complicated and/or too time-consuming for LPC determinations in human serum and plasma. DESIGN AND METHODS: We have developed a new enzymatic LPC assay, which uses lysophospholipase, glycerophosphorylcholine phosphodiesterase and choline oxidase, and which determines the quantities of hydrogen peroxide generated in the presence of peroxidase using an oxidative chromogenic reagent and 4-aminoantipyrine.
RESULTS: Various samples were mixed with LPC assay reagents, and their changes in absorbance were measured. The present method produced a linear calibration line between LPC concentration and absorbance change. It also measured only LPC, and not other phospholipids such as phosphatidylcholine, sphingomyelin and lysophosphatidic acid. The within-run and between-run coefficients of variation were 0.3-0.7% and 0.7%, respectively. The recovery of exogenous LPC added to control serum was 99.5-102.1%. The correlation coefficient obtained in a comparison with a method for analyzing fatty acids was 0.9122.
CONCLUSIONS: The present method is simple, specific for LPC, and can be applied with an automatic analyzer. It may also be useful for further studies of the biological functions of LPC as well as clinical applications in various disorders. Copyright 2002 The Canadian Society of Clinical Chemists

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270773     DOI: 10.1016/s0009-9120(02)00327-2

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  22 in total

1.  Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A2 and diet-induced obesity.

Authors:  Eric D Labonté; Paul T Pfluger; James G Cash; David G Kuhel; Juan C Roja; Daniel P Magness; Ronald J Jandacek; Matthias H Tschöp; David Y Hui
Journal:  FASEB J       Date:  2010-03-09       Impact factor: 5.191

2.  Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells.

Authors:  Michiko Mitsuishi; Seiko Masuda; Ichiro Kudo; Makoto Murakami
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia.

Authors:  Eric D Labonté; R Jason Kirby; Nicholas M Schildmeyer; April M Cannon; Kevin W Huggins; David Y Hui
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

4.  Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis.

Authors:  Keisuke Kakisaka; Sophie C Cazanave; Christian D Fingas; Maria E Guicciardi; Steven F Bronk; Nathan W Werneburg; Justin L Mott; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-13       Impact factor: 4.052

5.  Lysophosphatidylcholine modulates the aggregation of human islet amyloid polypeptide.

Authors:  Yanting Xing; Emily H Pilkington; Miaoyi Wang; Cameron J Nowell; Aleksandr Kakinen; Yunxiang Sun; Bo Wang; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Phys Chem Chem Phys       Date:  2017-11-22       Impact factor: 3.676

6.  Improved method for the quantification of lysophospholipids including enol ether species by liquid chromatography-tandem mass spectrometry.

Authors:  James G Bollinger; Hiromi Ii; Martin Sadilek; Michael H Gelb
Journal:  J Lipid Res       Date:  2009-08-29       Impact factor: 5.922

7.  Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

Authors:  A D Michel; E Fonfria
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

8.  Lysophosphatidylcholine as a predictor of postoperative complications after colorectal cancer surgery.

Authors:  Akihisa Matsuda; Marina Yamada; Satoshi Matsumoto; Nobuyuki Sakurazawa; Takeshi Yamada; Takeshi Matsutani; Masao Miyashita; Eiji Uchida
Journal:  Surg Today       Date:  2018-05-17       Impact factor: 2.549

9.  Enzymatic measurement of phosphatidic acid in cultured cells.

Authors:  Shin-ya Morita; Kazumitsu Ueda; Shuji Kitagawa
Journal:  J Lipid Res       Date:  2009-04-15       Impact factor: 5.922

10.  Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.

Authors:  Lin Ma; Hitoshi Uchida; Jun Nagai; Makoto Inoue; Jerold Chun; Junken Aoki; Hiroshi Ueda
Journal:  Mol Pain       Date:  2009-11-13       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.